title: Stem cell signaling as a target for novel drug discovery: recent progress in the WNT and Hedgehog pathways.
abstract: One of the most exciting fields in biomedical research over the past few years is stem cell biology, and therapeutic application of stem cells to replace the diseased or damaged tissues is also an active area in development. Although stem cell therapy has a number of technical challenges and regulatory hurdles to overcome, the use of stem cells as tools in drug discovery supported by mature technologies and established regulatory paths is expected to generate more immediate returns. In particular, the targeting of stem cell signaling pathways is opening up a new avenue for drug discovery. Aberrations in these pathways result in various diseases, including cancer, fibrosis and degenerative diseases. A number of drug targets in stem cell signaling pathways have been identified. Among them, WNT and Hedgehog are two most important signaling pathways, which are the focus of this review. A hedgehog pathway inhibitor, vismodegib (Erivedge), has recently been approved by the US FDA for the treatment of skin cancer, while several drug candidates for the WNT pathway are entering clinical trials. We have discovered that the stem cell signaling pathways respond to traditional Chinese medicines. Substances isolated from herbal medicine may act specifically on components of stem cell signaling pathways with high affinities. As many of these events can be explained through molecular interactions, these phenomena suggest that discovery of stem cell-targeting drugs from natural products may prove to be highly successful.
authors.affiliation: Curegenix Inc, Guangzhou 510663, China. man@curegenix.com
authors.forename: Songzhu Michael
authors.initials: SM
authors.lastname: An
authors.forename: Qiang Peter
authors.initials: QP
authors.lastname: Ding
authors.forename: Ling-song
authors.initials: LS
authors.lastname: Li
mesh_terms: D000813:Anilides / Q000494:pharmacology; D000818:Animals; D017277:Drug Approval; D015195:Drug Design; D055808:Drug Discovery / Q000379:methods*; D053823:Hedgehog Proteins / Q000378:metabolism; D006801:Humans; D058990:Molecular Targeted Therapy; D028321:Plant Preparations / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects; D033581:Stem Cell Transplantation / Q000379:methods; D013234:Stem Cells / Q000378:metabolism*; D060449:Wnt Signaling Pathway / Q000187:drug effects
chemical_list: D000813:Anilides; D053823:Hedgehog Proteins; C538724:HhAntag691; D028321:Plant Preparations; D011725:Pyridines